ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0323

Pain Prevalence and Factors Associated with Pain Levels in Patients with Idiopathic Inflammatory Myopathies

Didem Saygin1, Anne-Marie Malfait2, Kristin Wipfler3, Christopher G McKennan4, Jiaxuan Duan4, Kaleb Michaud5 and Yvonne Lee6, 1Rush University Medical Center, Chicago, IL, 2Rush University Medical Center, Division of Rheumatology, Chicago, IL, 3FORWARD, The National Databank for Rheumatic Diseases, Omaha, NE, 4University of Pittsburgh, Department of Statistics, Pittsburgh, PA, 5University of Nebraska Medical Center, Omaha, NE, 6Northwestern University, Chicago, IL

Meeting: ACR Convergence 2024

Keywords: Myositis, pain

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 16, 2024

Title: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster I

Session Type: Poster Session A

Session Time: 10:30AM-12:30PM

Background/Purpose: The cardinal symptom of idiopathic inflammatory myopathies (IIM) is muscle weakness leading to functional limitations in the majority of the patients. With a shift towards understanding the experiences of patients living with disease over the last decade, other disease symptoms that are important to patients are being increasingly recognized. IIM was traditionally believed to cause a painless weakness; thus, pain has long been overlooked as a disease symptom. In this study, our goal is to examine the prevalence of pain and factors associated with pain levels in adults with IIM.

Methods: FORWARD is a longitudinal prospective registry of adults with rheumatic diseases in the US who are primarily recruited from rheumatology clinics. Participants included in this study had physician diagnosis of IIM and completed comprehensive semiannual questionnaires on their health status including pain, fatigue, physical function, disease activity, sociodemographic features, and health services. We compared the patients who reported at least moderate pain ( >3 on 10-point numeric rating scale [NRS]) and those who had no-mild pain (≤3). Linear regression models were performed to examine the univariate association between baseline sociodemographic factors and pain levels. The significant variables were then included in a linear mixed model to assess the association between change in pain levels and disease activity over time.

Results: A total of 210 patients with IIM (age 55.3 ± 14.0, 78% women) were included in the study. Approximately 86% reported pain with an average of 3.5 (±2.9) and 24%-30% using NSAIDs and opioids, respectively. About 63% reported joint pain while 62% had muscle pain. Pain prevalence was similar across subgroups of disease subtype, sex, race, smoking, and obesity (Table 1). The patients who reported at least moderate pain were more likely to be younger and have history of smoking, higher BMI, lower education level, total income, comorbidity index, depression, and anxiety (Table 2). These patients with at least moderate pain also had worse patient global disease activity, physical function, fatigue, polysymptomatic distress, and quality of life than those who had no-mild pain. Pain was significantly associated with lower health satisfaction and higher number of emergency room visits. A significant association was observed between pain levels and age, race, smoking, education level and total income on regression models (Table 3). After controlling for these variables, one unit increase in patient global disease activity was associated with an increase of 0.21 in pain levels over time.

Conclusion: In this prospective observational study with IIM patients from a US-wide longitudinal registry, pain was prevalent and was associated with poor sociodemographic factors, clinical outcomes, health satisfaction and care utilization. Results highlight the critical need to better understand the pain experienced by patients with IIM to best address the needs of the patients and provide patient-centric care.   

Supporting image 1

Table 1. Prevalence and intensity of pain across subgroups (N = 210).

Abbreviations: SD: Standard deviation; IIM: Idiopathic inflammatory myopathy; DM: Dermatomyositis; PM: Polymyositis; IMNM: Immune mediated necrotizing myopathy

Supporting image 2

Table 2. Characteristics of the subgroups of pain numeric rating scale ≤3 vs >3.

Values represent mean ± SD or n (%)
Abbreviations: VAS: Visual analog scale, HAQ: Health Assessment Questionnaire, NSAIDs: Nonsteroidal anti-inflammatory drugs.

Supporting image 3

Table 3. Univariate linear regression model and multivariable linear mixed models for pain (continuous variable), sociodemographic factors and disease activity.

*p<0.005
†The model included pain levels as dependent variable, patient global disease activity as independent variable, and other variables as confounders.
Abbreviations: SE: Standard error


Disclosures: D. Saygin: None; A. Malfait: Averitas, 2, Orion, 5; K. Wipfler: None; C. McKennan: None; J. Duan: None; K. Michaud: None; Y. Lee: Cigna-Express Scripts, 8, CVS Health, 8, GE Healthcare, 8.

To cite this abstract in AMA style:

Saygin D, Malfait A, Wipfler K, McKennan C, Duan J, Michaud K, Lee Y. Pain Prevalence and Factors Associated with Pain Levels in Patients with Idiopathic Inflammatory Myopathies [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/pain-prevalence-and-factors-associated-with-pain-levels-in-patients-with-idiopathic-inflammatory-myopathies/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/pain-prevalence-and-factors-associated-with-pain-levels-in-patients-with-idiopathic-inflammatory-myopathies/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology